cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs ChemPartner

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axcelead/chempartner

CategoryAxcelead Drug Discovery Partners, Inc.ChemPartner
Listed sitecrocro
SummaryAxcelead provides integrated drug discovery research services across small molecules, nucleic acids, antibodies, and peptides, with specialized expertise in oncology, immunology, and neurology. Founded in 2017 from Takeda's research base, the company serves pharmaceutical companies, bioventures, and academia with above-industry screening hit rates and project success metrics.Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Biomarker Assays
  • Flow Cytometry Services
  • Bioanalysis
  • Bioinformatics & Data Science
  • Genomics & Sequencing Services
  • Proteomics Services
  • Pathology & Histology Services
  • Translational Research
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • Protein Engineering
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Pathology & Histology Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Regulatory Affairs
Modalities
  • Small Molecule
  • Oligonucleotide
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Peptide
  • mRNA
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
Indications
  • Oncology
  • Immunology
  • Neurology
  • Nephrology
  • Metabolic
  • Cardiovascular
  • Oncology
  • Immunology
  • Neurology
LocationsData not yet provided.
  • Boston Center of Excellence, Watertown, Massachusetts, USA
  • United Kingdom, Sandwich, Kent, United Kingdom
  • Europe, Copenhagen, Denmark, Denmark
  • Chengdu, Chengdu, China
  • Jiangsu, Jiangsu, China
  • Shanghai, Shanghai, China
  • Malaysia, Malaysia, Malaysia
  • Australia, Australia, Australia
  • Copenhagen, Copenhagen, Denmark
  • Malaysia, Malaysia
  • Jiangsu, Jiangsu, China
  • Australia, Australia
CertificationsData not yet provided.
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: cGMP Manufacturing / GMP Production
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.